Santos, Edgardo S <br/><br/>
Treatment options after first-line immunotherapy in metastatic NSCLC.  [electronic resource] 

 -  Expert review of anticancer therapy  03 2020 
 - 221-228 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8328 
<br/><br/><label>Standard No.: </label>10.1080/14737140.2020.1738930  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Non-Small-Cell Lung--immunology<br/>Humans<br/>Immune Checkpoint Inhibitors--administration & dosage<br/>Immunotherapy--adverse effects<br/>Lung Neoplasms--immunology<br/>Quality of Life<br/>Survival Rate